Characteristics | Number (%) |
---|---|
Age, years (median) | 54.4 (35–72) |
Breast cancer clinical stage | |
IIA | 1 (14.3%) |
IIB | 3 (42.8%) |
IIIA | 1 (14.3%) |
IIIB | 2 (28.6%) |
Tumor biology | |
Luminal A | 6 (85.7%) |
Triple-negative | 1 (14.3%) |
Primary tumor treatment | |
Neoadjuvant chemotherapy | 1 (14.3%) |
Adjuvant chemotherapy | 2 (28.6%) |
Neoadjuvant + adjuvant chemotherapy | 4 (57.1%) |
Radical surgery | 3 (42.8%) |
Conservative surgery | 4 (57.1%) |
Adjuvant radiotherapy | 7 (100%) |
Hormone therapy | 6 (85.7%) |